Health
Drug to treat OCD could reduce hospitalisation risk in Covid patients, study in Lancet says – ThePrint
The study says antidepressant fluvoxamine could reduce the production of inflammatory molecules called cytokines that can be…
New Delhi: Fluvoxamine, an antidepressant used for the treatment of major depressive disorders and obsessive-compulsive disorder (OCD), can reduce the need for hospitalisation among high-risk Covid-19 patients, according to the results of a new clinical…
Continue Reading
-
Noosa News18 hours agoHelicopter pilots saving lives, providing food and fodder in flooded outback Queensland
-
Noosa News22 hours ago’Lethal new opioids’ prompt Wide Bay pill testing call
-
General18 hours agoInternal Revenue Service starts cutting 20,000 workers
-
Noosa News18 hours agoMan killed, woman seriously injured in collision in Wongabel, Atherton Tablelands, Queensland